Optimizing expression of Streptococcus pneumoniae surface protein a, PspA: Serocross-reactivity within families of antisera induced against clades 1 and 3

Molecular Biotechnology

Volumn 37, Issue 2, 2007, Pages 146-154

  Silva, Marcelo ^a   Cabrera Crespo, Joaquin ^a   Sbrogio Almeida, Maria E ^a   Miyaji, Eliane N ^a   Ho, Paulo L ^a   Leite, Luciana C C ^a   Lopes, Alexandre P Y ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Pneumococcal vaccine; Protein expression; PspA; Selection marker and Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCAL VACCINES; PROTEIN EXPRESSION; SELECTION MARKERS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA; CHROMATOGRAPHY; ESCHERICHIA COLI; GENE EXPRESSION; PROTEINS; VACCINES;

MOLECULAR BIOLOGY;

ANTISERUM; MEMBRANE PROTEIN; SURFACE PROTEIN A; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; ESCHERICHIA COLI; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STREPTOCOCCUS PNEUMONIA;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CROSS REACTIONS; GENE EXPRESSION; GENETIC VECTORS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; STREPTOCOCCUS PNEUMONIAE;

ESCHERICHIA COLI; MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 36249024270     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-007-0043-z     Document Type: Article

References (22)

1. Prescott, L. M., Harley, J. P., & Klein, D. A. (1996). Microbiology. USA: VMC BROWN Publishers.
2. Briles, D. E., Tart, R. C., Swiatlo, E., Dillard, J. P., Smith, P., Benton, K. A., Ralph, B. A., Brooks-Walter, A., Crain, M. J., Hollingshead, S. K., & McDaniel, L. S. (1998). Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clinical Microbiology Reviews, 11, 645-657.
3. Black, S., Shinefield, U., Ray, P., Edwi, L., & Fireman, B. (1998). Efficacy of heptavalente conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of northern California Keiser Permanent efficacy trial. ICAAC Abstracts, LB-9.
4. Velasco, A. E., Verheul, A. F. M., Verhoel, J., & Snippe, H. (1995) Streptococcus pneumoniae: Virulence factors, Pathogenesis and Vaccines. Microbiological Reviews 59, 591-603.
5. McDaniel, L. S., Scott, G., Kearney J. F., & Brilles, D. E. (1984). Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. Journal of Experimental Medicine, 160, 386-397.
6. Crain, M. J., Waltman, W. D., Turner, J. S., Yother, J., Talkington, D. F., McDaniel, L. S., Gray, B. M., & Brilles, D. E. (1990). Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular seritypes of Streptococcus pneumoniae. Infection and Immunity, 58, 3293-3299.
7. Waltman, W. D., MaDaniel, L. S., Gray, B. M., & Brilles, D. E. (1990). Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microbial Pathogenesis, 8, 61-60.
8. ANH-Hue, T. T., Fulgham, R. L., McCrory, M. A., Brilles, D. E., & Szalai, A. J. (1999). Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infection and Immunity, 67, 4720-4724.
9. Yother, J., & Brilles, D. E. (1992). Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analises. Journal of Bacteriology, 174, 601-609.
10. Hollingdhead, S. K., Becker, R.,& Briles, D. E. (2000). Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infection and Immunity ,68, 5889-5900.
11. Briles, D. E., Hollingshead, S. K., King, J., Swift, A., Braun, P. A., Park, M. K., Ferguson, L. M., Nahm, M. H., & Nabors, G. S. (2000). Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. Journal of Infectious Diseases, 182(6), 1694-1701.
12. Kolberg, J., Aase, A., Rodal, G., Littlejohn, J. E., & Jedrzejas, M. J. (2003). Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modeling. FEMS, 39, 265-273.
13. Nabors, G. S., Braun, P. A., Herrmann, D. J., Heise, M. L., Pyle, D. J., Gravenstein, S., Schilling, M., Ferguson, L. M., Hollingshead, S. K., Briles, D. E., & Becker, R. S. (2000). Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine, 18, 1743-1754.
14. Miyaji, E. N., Ferreira, D. M., Lopes, A. P., Brandileone, M. C., Dias, W. O., & Leite, L. C. (2002). Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infection and Immunity, 70, 5086-5090.
15. Pimenta, F. C., Ribeiro-Dias, F., Brandileone, M. C., Miyaji, E. N., Leite, L. C., & Sgambatti de Andrade, A. L. (2006). Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil. Journal Clinical Microbiology, 44, 2838-2843.
16. Ramos, C. R., Abreu, P. A., Nascimento, A. L., & Ho, P. L. (2004). A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Brazilian Journal of Médical and Biological Research, 37, 1103-1109.
17. Lamani, E., McPherson, D. T., Hollingshead, S. K., & Jedrzejas, M. J. (2000). Production, characterization, and crystallization of truncated forms of pneumococcal surface protein A from Escherichia coli. Protein Expression and Purification, 20(3), 379-388.
18. Jedrzejas, M. J., Hollingshead, S. K., Lebowitz, J., Chantalat, L., Briles D. E., & Lamani, E. (2000). Production and characterization of the functional fragment of pneumococcal surface protein A. Archives of Biochemistry and Biophysics, 373(1), 116-125.
19. Cebolla, A., Royo, J. L., De Lorenzo, V., & Santero, E. (2002). Improvement of recombinant protein yield by a combination of transcriptional amplification and stabilization of gene expression. Applied and Environmental Microbiology, 68, 5034-5041.
20. Williams, S. G., Cranenburgh, R. M., Weiss, A. M., Wrighton, C. J., Sherratt, D. J., & Hanak, J. A. (1998). Repressor titration: A novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Research, 26, 2120-2124.
21. Fiedler, M., & Skerra, A. (2001). proBA complementation of an auxotrophic E. coli strain improves plasmid stability and expression yield during fermenter production of a recombinant antibody fragment. Gene, 274, 111-118.
22. Kolodny, N., Kitov, S., Vassell, M. A., Miller, V. L., Ware, L. A., Fegeding, K., De La Vega, P., Sacci, J. B. Jr., & Lanar, D. E. (2001). Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. Journal of Chromatography B-Biomedical Science Applications, 762, 77-86.